In clinical trials involving psychedelics, neuroimaging scans are typically conducted before and after treatment rather than during acute dosing to serve as an objective index of treatment effects.

Authors

• Person: Not available Organization: Nature
  Neuroimaging in psychedelic drug development: past, present, and ...

Sources

• Neuroimaging in psychedelic drug development: past, present, and ... www.nature.com Nature via serper

Referenced by nodes (1)

• neuroimaging concept